ClinVar Genomic variation as it relates to human health
NM_170707.4(LMNA):c.460G>A (p.Glu154Lys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_170707.4(LMNA):c.460G>A (p.Glu154Lys)
Variation ID: 2883981 Accession: VCV002883981.1
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1q22 1: 156130720 (GRCh38) [ NCBI UCSC ] 1: 156100511 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 20, 2024 Feb 20, 2024 Oct 24, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_170707.4:c.460G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_733821.1:p.Glu154Lys missense NM_005572.4:c.460G>A MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_005563.1:p.Glu154Lys missense NM_001257374.3:c.124G>A NP_001244303.1:p.Glu42Lys missense NM_001282624.2:c.217G>A NP_001269553.1:p.Glu73Lys missense NM_001282625.2:c.460G>A NP_001269554.1:p.Glu154Lys missense NM_001282626.2:c.460G>A NP_001269555.1:p.Glu154Lys missense NM_001406983.1:c.460G>A NP_001393912.1:p.Glu154Lys missense NM_001406984.1:c.460G>A NP_001393913.1:p.Glu154Lys missense NM_001406985.1:c.460G>A NP_001393914.1:p.Glu154Lys missense NM_001406986.1:c.217G>A NP_001393915.1:p.Glu73Lys missense NM_001406987.1:c.217G>A NP_001393916.1:p.Glu73Lys missense NM_001406988.1:c.163G>A NP_001393917.1:p.Glu55Lys missense NM_001406989.1:c.124G>A NP_001393918.1:p.Glu42Lys missense NM_001406990.1:c.-45-3683G>A intron variant NM_001406991.1:c.460G>A NP_001393920.1:p.Glu154Lys missense NM_001406992.1:c.460G>A NP_001393921.1:p.Glu154Lys missense NM_001406993.1:c.-99G>A 5 prime UTR NM_001406994.1:c.-205G>A 5 prime UTR NM_001406995.1:c.-45-3683G>A intron variant NM_001406996.1:c.-99G>A 5 prime UTR NM_001406997.1:c.-99G>A 5 prime UTR NM_001406998.1:c.124G>A NP_001393927.1:p.Glu42Lys missense NM_001406999.1:c.-205G>A 5 prime UTR NM_001407000.1:c.-205G>A 5 prime UTR NM_001407001.1:c.-151-3683G>A intron variant NM_001407002.1:c.-45-3683G>A intron variant NM_001407003.1:c.-99G>A 5 prime UTR NM_170708.4:c.460G>A NP_733822.1:p.Glu154Lys missense NR_047544.1:n.1101G>A NR_047545.1:n.348G>A NC_000001.11:g.156130720G>A NC_000001.10:g.156100511G>A NG_008692.2:g.53148G>A NG_082201.1:g.919G>A LRG_254:g.53148G>A LRG_254t1:c.460G>A LRG_254p1:p.Glu154Lys LRG_254t2:c.460G>A LRG_254p2:p.Glu154Lys LRG_254t3:c.460G>A LRG_254p3:p.Glu154Lys - Protein change
- E154K, E42K, E55K, E73K
- Other names
- -
- Canonical SPDI
- NC_000001.11:156130719:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
LMNA | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
1845 | 2125 | |
LOC126805877 | - | - | - | GRCh38 | - | 157 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Oct 24, 2023 | RCV003743411.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Oct 24, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Charcot-Marie-Tooth disease type 2
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004509392.1
First in ClinVar: Feb 20, 2024 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 154 of the LMNA protein … (more)
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 154 of the LMNA protein (p.Glu154Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 31303467). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMNA protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy. | Martins E | Revista portuguesa de cardiologia | 2019 | PMID: 31303467 |
Text-mined citations for this variant ...
HelpRecord last updated Sep 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.